Microvesicles as biomarkers in NAFLD : a clinician’s point of view
Sign in to receive more information about videos like this
Prof Rautou, France, sheds light on microvesicles, which reflect apoptosis and cell activation. He discusses what we know about microvesicles in NASH and the rationale to consider them as biomarkers in liver disease.
This content is restricted to site members. If you are an existing user, please log in. New users may register below.